BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foster BM, Zaidi D, Young TR, Mobley ME, Kerr BA. CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. Biomedicines 2018;6:E31. [PMID: 29518044 DOI: 10.3390/biomedicines6010031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Vignjević Petrinović S, Jauković A, Milošević M, Bugarski D, Budeč M. Targeting Stress Erythropoiesis Pathways in Cancer. Front Physiol 2022;13:844042. [DOI: 10.3389/fphys.2022.844042] [Reference Citation Analysis]
2 Kim GH, Cho YM, Kim SW, Park JM, Yoon SY, Jeong G, Shin DM, Ju H, Jeong SU. Synaptophysin, CD117, and GATA3 as a Diagnostic Immunohistochemical Panel for Small Cell Neuroendocrine Carcinoma of the Urinary Tract. Cancers (Basel) 2022;14:2495. [PMID: 35626098 DOI: 10.3390/cancers14102495] [Reference Citation Analysis]
3 de Toledo MA, Fu X, Kluge F, Götz K, Schmitz S, Wanek P, Schüler HM, Pannen K, Chatain N, Koschmieder S, Brümmendorf TH, Zenke M. CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout. Stem Cell Research 2022;60:102732. [DOI: 10.1016/j.scr.2022.102732] [Reference Citation Analysis]
4 Patel C, Shi L, Whitesides JF, Foster BM, Fajardo RJ, Quillen EE, Kerr BA. A New Method of Bone Stromal Cell Characterization by Flow Cytometry. Curr Protoc 2022;2:e400. [PMID: 35349226 DOI: 10.1002/cpz1.400] [Reference Citation Analysis]
5 Horvathova Kajabova V, Soltysova A, Demkova L, Plesnikova P, Lyskova D, Furdova A, Babal P, Smolkova B. KIT Expression Is Regulated by DNA Methylation in Uveal Melanoma Tumors. Int J Mol Sci 2021;22:10748. [PMID: 34639089 DOI: 10.3390/ijms221910748] [Reference Citation Analysis]
6 Foster BM, Langsten KL, Mansour A, Shi L, Kerr BA. Tissue distribution of stem cell factor in adults. Exp Mol Pathol 2021;122:104678. [PMID: 34450114 DOI: 10.1016/j.yexmp.2021.104678] [Reference Citation Analysis]
7 Kim JO, Kim KH, Baek EJ, Park B, So MK, Ko BJ, Ko HJ, Park SG. A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors. Mol Oncol 2021. [PMID: 34407310 DOI: 10.1002/1878-0261.13084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Koshiol J, Argirion I, Liu Z, Kim Lam T, O'Brien TR, Yu K, McGlynn KA, Petrick JL, Pinto L, Chen CJ, Hildesheim A, Pfeiffer RM, Lee MH, Yang HI. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals. Aliment Pharmacol Ther 2021;54:833-42. [PMID: 34286851 DOI: 10.1111/apt.16524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Masoumi J, Jafarzadeh A, Abdolalizadeh J, Khan H, Philippe J, Mirzaei H, Mirzaei HR. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects. Acta Pharm Sin B 2021;11:1721-39. [PMID: 34386318 DOI: 10.1016/j.apsb.2020.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
10 Yang W, Kim D, Kim DK, Choi KU, Suh DS, Kim JH. Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. Int J Mol Sci 2021;22:5059. [PMID: 34064635 DOI: 10.3390/ijms22105059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Motohara T, Yoshida GJ, Katabuchi H. The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance. Semin Cancer Biol 2021:S1044-579X(21)00099-7. [PMID: 33812986 DOI: 10.1016/j.semcancer.2021.03.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ahn R, Ursini-Siegel J. Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors. Int J Mol Sci 2021;22:2608. [PMID: 33807608 DOI: 10.3390/ijms22052608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gavriilidis GI, Ntoufa S, Papakonstantinou N, Kotta K, Koletsa T, Chartomatsidou E, Moysiadis T, Stavroyianni N, Anagnostopoulos A, Papadaki E, Tsiftsoglou AS, Stamatopoulos K. Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia. Haematologica 2021;106:692-700. [PMID: 32336682 DOI: 10.3324/haematol.2019.236513] [Reference Citation Analysis]
14 Harris KS, Shi L, Foster BM, Mobley ME, Elliott PL, Song CJ, Watabe K, Langefeld CD, Kerr BA. CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance. Sci Rep 2021;11:1465. [PMID: 33446896 DOI: 10.1038/s41598-021-81126-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schmidt J, Pilbauerova N, Soukup T, Suchankova-Kleplova T, Suchanek J. Low Molecular Weight Hyaluronic Acid Effect on Dental Pulp Stem Cells In Vitro. Biomolecules 2020;11:E22. [PMID: 33379324 DOI: 10.3390/biom11010022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang M, Liang J, Jiang S, Xu L, Wu Y, Awadasseid A, Zhao X, Xiong X, Sugiyama H, Zhang W. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression. European Journal of Medicinal Chemistry 2020;207:112704. [DOI: 10.1016/j.ejmech.2020.112704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
17 Wang H, Cui G, Yu B, Sun M, Yang H. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies. Curr Pharm Des 2020;26:1979-93. [PMID: 32268862 DOI: 10.2174/1381612826666200408102305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Aburjania Z, Whitt JD, Jang S, Nadkarni DH, Chen H, Rose JB, Velu SE, Jaskula-Sztul R. Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells. Molecules 2020;25:E4940. [PMID: 33114525 DOI: 10.3390/molecules25214940] [Reference Citation Analysis]
19 Su B, Huang T, Jin Y, Yin H, Qiu H, Yuan X. Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways. Gastric Cancer 2021;24:352-67. [PMID: 33030616 DOI: 10.1007/s10120-020-01126-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Jobani BM, Mohebi E, Najafzadeh N. In Vitro Anticancer Effects of All-trans Retinoic Acid in Combination with Dacarbazine against CD117+ Melanoma Cells. Drug Res (Stuttg) 2020;70:563-9. [DOI: 10.1055/a-1240-0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Pinheiro LHS, Trindade LD, Costa FO, Silva NL, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, da Cruz GS, de Lyra Junior DP, Schimieguel DM. Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and Meta-Analysis. Int J Hematol Oncol Stem Cell Res 2020;14:274-88. [PMID: 33603989 DOI: 10.18502/ijhoscr.v14i4.4484] [Reference Citation Analysis]
22 Kalathil SG, Wang K, Hutson A, Iyer R, Thanavala Y. Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. Oncoimmunology 2020;9:1824863. [PMID: 33101775 DOI: 10.1080/2162402X.2020.1824863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chen B, Ye P, Chen Y, Liu T, Cha JH, Yan X, Yang WH. Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance. Front Oncol 2020;10:1657. [PMID: 33014829 DOI: 10.3389/fonc.2020.01657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Du S, Wagner N, Wagner KD. The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis. PPAR Res 2020;2020:3608315. [PMID: 32855630 DOI: 10.1155/2020/3608315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yao Y, Sun S, Cao M, Mao M, He J, Gai Q, Qin Y, Yao X, Lu H, Chen F, Wang W, Luo M, Zhang H, Huang H, Ju J, Bian XW, Wang Y. Grincamycin B Functions as a Potent Inhibitor for Glioblastoma Stem Cell via Targeting RHOA and PI3K/AKT. ACS Chem Neurosci 2020;11:2256-65. [PMID: 32584547 DOI: 10.1021/acschemneuro.0c00206] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Muñoz-Galván S, Carnero A. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer. Cells 2020;9:E1402. [PMID: 32512891 DOI: 10.3390/cells9061402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
27 Kim JO, Kim HN, Kim KH, Baek EJ, Park JY, Ha K, Heo DR, Seo MD, Park SG. Development and characterization of a fully human antibody targeting SCF/c-kit signaling. Int J Biol Macromol 2020;159:66-78. [PMID: 32437800 DOI: 10.1016/j.ijbiomac.2020.05.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Sangeetha KN, Vennila R, Secunda R, Sakthivel S, Pathak S, Jeswanth S, Surendran R. Functional variations between Mesenchymal Stem Cells of different tissue origins: A comparative gene expression profiling. Biotechnol Lett 2020;42:1287-304. [PMID: 32372268 DOI: 10.1007/s10529-020-02898-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Giudice V, Mensitieri F, Izzo V, Filippelli A, Selleri C. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases. Int J Mol Sci 2020;21:E3252. [PMID: 32375354 DOI: 10.3390/ijms21093252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
30 Fang CH, Lin YT, Liang CM, Liang SM. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling. J Biomed Sci 2020;27:42. [PMID: 32169072 DOI: 10.1186/s12929-020-00638-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
31 Wu D, Xue X, Gao C, Liu Y, Wang T, Li L, Tong X, Li F, Xu J. Rhubarb-Evoke Mucus Secretion through Aggregation and Degranulation of Mast Cell in the Colon of Rat: In vivo and ex vivo studies. Sci Rep 2019;9:19375. [PMID: 31852975 DOI: 10.1038/s41598-019-55937-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
32 Yiau SK, Lee C, Mohd Tohit ER, Chang KM, Abdullah M. Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia. J Recept Signal Transduct Res 2019;39:276-82. [PMID: 31509041 DOI: 10.1080/10799893.2019.1660899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Houshmand M, Blanco TM, Circosta P, Yazdi N, Kazemi A, Saglio G, Zarif MN. Bone marrow microenvironment: The guardian of leukemia stem cells. World J Stem Cells 2019; 11(8): 476-490 [PMID: 31523368 DOI: 10.4252/wjsc.v11.i8.476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
34 Kuciauskas D, Dreize N, Ger M, Kaupinis A, Zemaitis K, Stankevicius V, Suziedelis K, Cicenas J, Graves LM, Valius M. Proteomic Analysis of Breast Cancer Resistance to the Anticancer Drug RH1 Reveals the Importance of Cancer Stem Cells. Cancers (Basel) 2019;11:E972. [PMID: 31336714 DOI: 10.3390/cancers11070972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Nallanthighal S, Heiserman JP, Cheon DJ. The Role of the Extracellular Matrix in Cancer Stemness. Front Cell Dev Biol. 2019;7:86. [PMID: 31334229 DOI: 10.3389/fcell.2019.00086] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 25.0] [Reference Citation Analysis]
36 Zong X, Nephew KP. Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting. Cancers (Basel) 2019;11:E934. [PMID: 31277278 DOI: 10.3390/cancers11070934] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
37 Mazzoldi EL, Pavan S, Pilotto G, Leone K, Pagotto A, Frezzini S, Nicoletto MO, Amadori A, Pastò A. A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer. Cell Death Dis 2019;10:412. [PMID: 31138788 DOI: 10.1038/s41419-019-1656-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
38 Gutiérrez-Hoya A, Zerecero-Carreón O, Valle-Mendiola A, Moreno-Lafont M, López-Santiago R, Weiss-Steider B, Soto-Cruz I. Cervical Cancer Cells Express Markers Associated with Immunosurveillance. J Immunol Res 2019;2019:1242979. [PMID: 31198791 DOI: 10.1155/2019/1242979] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Yousefi M, Mamipour M, Sokullu SE, Ghaderi S, Amini H, Rahbarghazi R. Toll-like receptors in the functional orientation of cardiac progenitor cells. J Cell Physiol 2019;234:19451-63. [PMID: 31025370 DOI: 10.1002/jcp.28738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Francipane MG, Bulanin D, Lagasse E. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure. Int J Mol Sci 2019;20:E1817. [PMID: 31013771 DOI: 10.3390/ijms20081817] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
41 Rajput S, Minhas K, Azam I, Shaikh U, Hussain A, Lalani EN. LMP1 expression in bone marrow trephines of patients with multiple myeloma confers a survival advantage. Leuk Lymphoma 2019;60:1991-2001. [PMID: 30912465 DOI: 10.1080/10428194.2018.1563697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 He C, Liu C, Wang L, Sun Y, Jiang Y, Hao Y. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma. Cell Death Dis 2019;10:65. [PMID: 30683853 DOI: 10.1038/s41419-019-1347-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
43 He C, Sun J, Liu C, Jiang Y, Hao Y. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin. Clin Epigenetics 2019;11:8. [PMID: 30651137 DOI: 10.1186/s13148-018-0605-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
44 Chen R, Li H, Li Y, Fazli L, Gleave M, Nappi L, Dong X. Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation. Front Oncol 2018;8:594. [PMID: 30581773 DOI: 10.3389/fonc.2018.00594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
45 Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, Abou-Kheir W. Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. Front Oncol. 2018;8:347. [PMID: 30211124 DOI: 10.3389/fonc.2018.00347] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 14.5] [Reference Citation Analysis]